SINT — Sintx Technologies, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1269026 ·
Last close
$2.43
Market Cap
$10.50M
52W High
$3.00
52W Low
$1.99
ADV30
37,171
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 300,000 | 64,000 | -3,207,000 | -2,821,000 | 7,811,000 | 1,889,000 | 6,907,000 |
| Dec 2025 | 188,000 | 86,000 | -2,318,000 | -2,215,000 | 9,506,000 | 4,140,000 | 6,577,000 |
| Sep 2025 | 150,000 | 35,000 | -3,355,000 | -3,539,000 | 11,364,000 | 6,250,000 | 7,296,000 |
| Jun 2025 | 100,000 | 6,000 | -2,665,000 | -2,318,000 | 9,195,000 | 4,320,000 | 5,207,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,571,000
Investing CF
$913,000
Financing CF
$8,200,000
CapEx
$-335,000
Dividends Paid
—
Buybacks
$-133,000
EPS Diluted TTM
$-12.62
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-292,102,000
Inventory
$825,000
Receivables
$178,000
ST Investments
—
EBIT TTM
$-10,312,000
Pretax Income TTM
$-10,364,000
Interest Exp TTM
$52,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,029,000
EBITDA
$-11,069,000
Free Cash Flow
$-3,699,750
Enterprise Value
$11,697,077
Total Cash
$1,889,000
Total Debt
$3,263,000
Shares Out
4,319,279
Trailing EPS
$-5.66
Book Value
$0.22
ROE
-311.4%
ROA
-73.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 729,000 | -10,721,000 | -10,364,000 | 9,506,000 | 6,577,000 | — | -8,571,000 |
| Dec 2024 | 1,246,000 | -9,038,000 | -11,024,000 | 9,413,000 | 5,519,000 | — | -8,642,000 |
| Dec 2023 | 1,226,000 | -13,358,000 | -8,259,000 | 15,365,000 | 6,593,000 | — | -14,115,000 |
| Dec 2022 | 601,000 | -11,335,000 | -12,039,000 | 15,773,000 | 10,069,000 | — | -10,263,000 |
TTM Snapshot
Revenues TTM
$5,998,000
NetIncome TTM
$-4,932,000
OpCashFlow TTM
$0
Assets (Latest)
$47,583,000
Forward EPS
$-1.70
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NXL | Nexalin Technology, Inc. | $10.34M | $0.48 | — |
| RGNT | REGENTIS BIOMATERIALS LTD. | $11.19M | $2.16 | — |
| ALUR | ALLURION TECHNOLOGIES, INC. | $11.25M | $0.75 | — |
| ALRTF | ALR Technologies SG Ltd. | $9.68M | $0.01 | — |
| VVOS | Vivos Therapeutics, Inc. | $8.99M | $0.65 | — |
News headlines (Yahoo Finance, 1h cache)
SINTX Technologies to Present at the LD Micro Invitational XVI Conference
2026-05-17 19:30 · Yahoo
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
2026-05-15 13:15 · Yahoo
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
2026-05-13 22:10 · Yahoo
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
2026-03-23 13:15 · Yahoo
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant
2026-03-19 11:30 · Yahoo
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
2026-02-18 13:30 · Yahoo
SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5
2026-01-29 14:00 · Yahoo
SINTX Technologies to Participate in Sidoti & Company Investor Conference
2025-12-08 14:00 · Yahoo
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
2025-12-01 13:30 · Yahoo
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
2025-11-13 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.